Bicycle Therapeutics Plc (BCYC)
3.89
+0.08
(+2.10%)
USD |
NASDAQ |
Oct 09, 16:00
3.89
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Free Cash Flow : -207.47M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -207.47M |
| March 31, 2026 | -231.83M |
| December 31, 2025 | -252.61M |
| September 30, 2025 | -242.07M |
| June 30, 2025 | -211.70M |
| March 31, 2025 | -182.50M |
| December 31, 2024 | -166.03M |
| September 30, 2024 | -204.41M |
| June 30, 2024 | -164.98M |
| March 31, 2024 | -85.69M |
| December 31, 2023 | -63.80M |
| September 30, 2023 | -50.17M |
| June 30, 2023 | -56.51M |
| March 31, 2023 | -123.11M |
| December 31, 2022 | -105.03M |
| September 30, 2022 | -80.52M |
| Date | Value |
|---|---|
| June 30, 2022 | -50.94M |
| March 31, 2022 | -30.84M |
| December 31, 2021 | -16.82M |
| September 30, 2021 | -24.90M |
| June 30, 2021 | -56.53M |
| March 31, 2021 | -56.65M |
| December 31, 2020 | -19.14M |
| September 30, 2020 | -7.102M |
| June 30, 2020 | -8.712M |
| March 31, 2020 | -4.128M |
| December 31, 2019 | -30.29M |
| September 30, 2019 | -34.10M |
| June 30, 2019 | -27.40M |
| March 31, 2019 | -25.12M |
| December 31, 2018 | -27.21M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Autolus Therapeutics Plc | -240.12M |
| Akari Therapeutics Plc | -10.74M |
| Cellectis SA | -45.36M |
| DBV Technologies SA | -152.18M |
| Biodexa Pharmaceuticals Plc | -10.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -49.69M |
| Cash from Investing (Quarterly) | -0.266M |
| Cash from Financing (Quarterly) | -0.0501M |
| Free Cash Flow Per Share (Quarterly) | -0.7157 |
| Free Cash Flow to Equity (Quarterly) | -49.23M |
| Free Cash Flow to Firm (Quarterly) | -49.92M |
| Free Cash Flow Yield | -76.70% |